PerioSept(r)

DRUG2 trials

Sponsors

Geistlich Pharma AG

Conditions

Periodontitis

Phase 1

A Phase I/II Study to Evaluate the Safety and Efficacy of PerioSept® as Adjunct to SRP in Subjects With Periodontitis

CompletedNCT02313883

Geistlich Pharma AGPeriodontitis

Start: 2015-07-31End: 2018-07-02Updated: 2019-09-17

Phase 2

Trial to Evaluate Safety, Tolerability, Efficacy of PerioSept® as Adjunct to SRP in Subjects With Periodontitis

CompletedNCT04093895

Geistlich Pharma AGPeriodontitis

Start: 2019-08-26End: 2020-09-25Updated: 2020-10-19